Sheila Moriber Katz

The Scientist Date: February 17, 1997 THE SCIENTIST® The Newspaper for the Life Sciences Professional (609)-786-7207 For Fast Service "Drenched by monsoons of fact, I rely on my umbrella, THE SCIENTIST, to shield me from all but the most useful news in my scientific pursuits." SHEILA MORIBER KATZ, Special Assistant to the President and CEO, Allegheny Health, Education, and Research Foundation (AHERF); Professor, Pathology and Laboratory Medicine, Allegheny University of the Health Scie

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: February 17, 1997

SHEILA MORIBER KATZ, Special Assistant to the President and CEO,
Allegheny Health, Education, and Research Foundation (AHERF);
Professor, Pathology and Laboratory Medicine, Allegheny University of the Health Sciences, Philadelphia

As dean (interim) of Hahnemann University School of Medicine, Philadelphia, she helped position that institution for its innovative merger with the Medical College of Pennsylvania/AHERF, the first merger of two medical schools in the United States. At Allegheny University of the Health Sciences, Katz also cofounded Philadelphia's only School of Public Health, a globally unique, community-oriented institution of learning.

Katz is a scientist, educator, physician/clinician, and artist. Her investigations uncovered the cause of Legionnaires' disease, and she was the first to find the causative organism, Legionella pneumophila. A serious poet, Katz, as cofounder and president of the International Arts-Medicine Association, advances the healing power of the arts.

A regular reader of THE SCIENTIST, Katz says: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies